Neuronet Presentations

Oral presentation: "NEURONET and public-private partnerships in research". L. Killin (Parkinson's Research in Ireland), 7 April 2022, Virtual.  Recording

 

 

 

 

 

---

Oral presentation: “Gaps, Challenges And Priorities For Neurodegenerative Disease Research And Health Technology Assessment”. NICE (HTAi 2022 Conference), 28 June 2022, Utrecht (Netherlands).
 

---

Oral presentations as part of our public event during the 31st Alzheimer Europe Conference (virtual) from 29 November to 1 December:

Elevating the patient voice: public involvement in Innovative Medicines Initiative neurodegeneration projects

Collaboration and best practice: common challenges & lessons learned from the Innovative Medicines Initiative neurodegeneration portfolio

From bench to bedside: preclinical research in Innovative Medicines Initiative neurodegeneration projects

Looking to the future: Impact of the Innovative Medicines Initiative’s neurodegeneration portfolio

 

 

---

Oral presentation: "Lessons learned from IMI funded projects – the findings of the Neuronet consortium and the IMI neurodegeneration portfolio'". C. Diaz (European Parliament Workshop), 28 September 2021, Virtual. Recording

 

 

 

---

Oral presentation: "How IMI projects have addressed the challenge & 'moved the needle'". C. Diaz (IMI Impact on dementia), 15 June 2021, Virtual. Presentation  Recording

 

 

 

 

---

Oral presentation: “National approaches to pricing, reimbursement and health technology assessments”. NICE (Virtual Alzheimer’s Association Academy meeting), 13 July 2021, Virtual.
 

---

Oral presentation: "Adopting best practice on data sharing: report on Neuronet Working Group activities".  M. Rinaldi  & L. Steukers (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.

Oral presentation: "Adopting best practice on patient privacy – report on Neuronet Working Group activities".  A. Bradshaw (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.

Oral presentation: "A framework for regulatory and health technology assessment engagement in neurodegenerative disease research". D. O'Rourke & J. Bouvy (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.

Oral presentation: "The neurodegeneration portfolio of the Innovative Medicines Initiative – from project results to sustainable assets". C. Diaz, S. Pla, J. Georges, A. Bradshaw, J. Bouvy, D. O'Rourke, L. Pradier, M. Rinaldi & L. Steukers. (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.

 

---

 

Poster presentation: "Regulatory and HTA Engagement in Neurodegenerative Disease Research: A Decision Tool".  D. O'Rourke, P. Jonsson and J. Bouvy (ISPOR Europe 2019),  2-7 November 2019, Copenhagen (Denmark).

 

 

 

 

 

 

---

Oral presentation: "Neuronet – Efficiently Networking European Neurodegeneration Research”. C. Diaz, S. Pla, N. Coll, J. Georges, J. Bouvy, H. Marston, L. Pradier, A. Roach, M. Traber, E. Merlo-Pich and D. Pemberton (Alzheimer Europe Conference 2019), 23-25 October 2019, The Hague (Netherlands).